Strategic partnerships Opportunity to engage with a government-backed UK biotechnology hub focused on accelerating cell and gene therapies from research to commercialisation, presenting a channel to connect partner organisations, CROs, and biotech firms seeking early and scalable solutions.

Clinical and regulatory CGT Catapult offers capabilities in clinical trials, process development, manufacturing, regulatory, health economics and market access, creating cross-sell potential to biotech startups and established companies needing end-to-end support.

Global readiness The goal to make the UK a leading hub for advanced therapies signals a readiness to collaborate with international partners seeking UK-based development, testing or manufacturing capabilities to accelerate global market entry.

Innovation ecosystem Active collaboration with Innovate UK and industry partners, plus a broad tech stack and distributed partnerships, provides entrances for technology licensing, joint ventures and funded research programs.

Growth and funding signals Revenue size and recent leadership appointments, along with notable partnerships and events, indicate a growth trajectory and potential for scalable service engagements, licensing deals, or co-development opportunities.